ORF_ID,Contig,Start,Stop,Orientation,Cut_Off,Pass_Bitscore,Best_Hit_Bitscore,Best_Hit_ARO,Best_Identities,ARO,Model_type,SNPs_in_Best_Hit_ARO,Other_SNPs,Drug Class,Resistance Mechanism,AMR Gene Family,Predicted_DNA,Predicted_Protein,CARD_Protein_Sequence,Percentage Length of Reference Sequence,ID,Model_ID,Nudged,Note,Bin,Sample
NODE_15971_length_4584_cov_45.964278_5 # 2709 # 3179 # 1 # ID=158_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_15971_length_4584_cov_45.964278_5,2709,3179,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",CMC035.B.bin.r.91,CMC035.B-metaspades_091
NODE_29790_length_3241_cov_9.487990_6 # 2694 # 3164 # 1 # ID=150_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_29790_length_3241_cov_9.487990_6,2694,3164,+,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",CMC038.A.bin.r.58,CMC038.A-metaspades_058
NODE_47702_length_2346_cov_10.748347_4 # 2268 # 2345 # -1 # ID=236_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.295,NODE_47702_length_2346_cov_10.748347_4,2268,2345,-,Strict,700,19.2458,CMY-46,100,3002057,protein homolog model,n/a,n/a,cephamycin,antibiotic inactivation,CMY beta-lactamase,CAAATTACAGTACCGAAAAACGAAGACATCTACGAAAACAAAGAAAATGTTTTGATTATCCCAAATTCTGAAATTTAA,QITVPKNEDIYENKENVLIIPNSEI,MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPKNEQKDYAWGYREGKAVHVSPGQLDAEAYGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ,6.56,gnl|BL_ORD_ID|1081|hsp_num:0,1170,TRUE,loose hit with at least 95 percent identity pushed strict,CMC038.A.bin.r.58,CMC038.A-metaspades_058
NODE_2793_length_1191_cov_11.9_1 # 1 # 69 # -1 # ID=523_1;partial=10;start_type=ATG;rbs_motif=TAAA;rbs_spacer=13bp;gc_cont=0.188,NODE_2793_length_1191_cov_11.9_1,1,69,-,Strict,520,19.631,fexB,100,3007019,protein homolog model,n/a,n/a,phenicol antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,ATGCAAAATGTTAAAAACCCATTTATACTATTAATTAATATTAAAAAAATACGTGATAATTGTGAAATC,MQNVKNPFILLINIKKIRDNCEI,MNHQNEKNIASNVLLISILGLSVLVGSVTADMVNPVLGVIGKELGGSEAQVSWVVSGVALVLSIAIPFYGRLSDFLNIKKLFTNGFLILTIGSLICIFAPNLIILVLGRMFQGAGMAAIPVLSIVIISKIYPPGQRGRILGIIAGCIGVGTAGGPIFGGVVGQLLGWQSLFWVTFVLGLIIVLGVQISMPKIESPDNNSHQNFDVLGGLLLGLTVGGFLLGITLSEMYGLISIQTTTSFSISMIALIVLIYRVINVKNPFIPPVILKNRLYVSSIFIVFLSMFAYVSMLVFIPLLVVEVNGLSTGQAGLILLSGGVAVAILSPIVGRLSDKVHPKILLLVGLIIMGLSSLYMSFVAGASPVLLSIGSLGIGIAFAFINSPVNNVAVLALPKEQVGVGTGLFQGAMYLGAGTGASLIGALLSMRHGVKASFNPFYTLTAPHYSDIFLTITCIVLVALIVTLNISSRDLKQ,4.9,gnl|BL_ORD_ID|4663|hsp_num:0,5733,TRUE,loose hit with at least 95 percent identity pushed strict,ERS11702722.bin.r.1,ERS11702722-megahit_001
NODE_218_length_7662_cov_54.9_7 # 4658 # 5128 # 1 # ID=86_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_218_length_7662_cov_54.9_7,4658,5128,+,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS11702729.bin.r.3,ERS11702729-megahit_003
NODE_687_length_5066_cov_14.6_4 # 1889 # 2359 # -1 # ID=66_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_687_length_5066_cov_14.6_4,1889,2359,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS11702732.bin.r.6,ERS11702732-megahit_006
NODE_6159_length_1520_cov_16.2_1 # 2 # 64 # -1 # ID=453_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.540,NODE_6159_length_1520_cov_16.2_1,2,64,-,Strict,300,18.8606,AAC(3)-IXa,100,3002543,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,AAC(3),ATGGAATGTTTTATAGGTGATGGGTTTGTTGGCGGCTGCGATGTTGTAGGCGCGCGCGGTGTC,MECFIGDGFVGGCDVVGARGV,MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR,7.47,gnl|BL_ORD_ID|1870|hsp_num:0,2030,TRUE,loose hit with at least 95 percent identity pushed strict,ERS11702732.bin.r.6,ERS11702732-megahit_006
NODE_230_length_4401_cov_10.8_9 # 4250 # 4399 # -1 # ID=26_9;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.320,NODE_230_length_4401_cov_10.8_9,4250,4399,-,Strict,690,21.1718,MexJ,100,3003692,protein homolog model,n/a,n/a,macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,TTATGGATTATAGGTTTCTTATTATTCTTTGTATCGCCTAATCTATGGTTGTTAAGTTTATTCTTAGCTGCTTGCGGATTGTTATTAAAAGTAGCTTCAAAGGTTGGTTTAATTGGACTACTTATGAGGGAAGATATTGATAAGGAGTAG,LWIIGFLLFFVSPNLWLLSLFLAACGLLLKVASKVGLIGLLMREDIDKE,MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE,13.35,gnl|BL_ORD_ID|2015|hsp_num:0,2205,TRUE,loose hit with at least 95 percent identity pushed strict,ERS11702760.bin.r.1,ERS11702760-megahit_001
NODE_1300_length_1919_cov_10.1_3 # 1774 # 1917 # -1 # ID=259_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.222,NODE_1300_length_1919_cov_10.1_3,1774,1917,-,Strict,500,22.3274,MYX-1,100,3006955,protein homolog model,n/a,n/a,carbapenem,antibiotic inactivation,MYX beta-lactamase,CCTATATTTAAAAAAAGAATTAAAATTTTAAAAGATAGAAAAGAATGGCACAGGGATAGTGGTGTGTATATTATTGAAGATGCTATCTTAGAAGATAAATGATTTATAAATCAATTTCTTCTAAAAATTTACTTATTTTATTAG,PIFKKRIKILKDRKEWHRDSGVYIIEDAILEDKWFINQFLLKIYLFY,MTLFPLRWFCAGALLITLSTACTRSTPAATVERNIPVKAQSQGPDEYVLADDVSVRKLAPGVWLHITVVTLEPFGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAAVVTHFHEDRLGGVPALAPHGIPVHGLEETARIATSLGLPGPTETFAKTSTVDSLELFFPGAGHAKDNIVVWHRDSGVLFGGCFVKDGASTNLGNVADADVAAWPASLSRTRQRFPEARVVVPGHGQPGGPELLGHTEALLR,18.01,gnl|BL_ORD_ID|3707|hsp_num:0,4777,TRUE,loose hit with at least 95 percent identity pushed strict,ERS11702760.bin.r.1,ERS11702760-megahit_001
NODE_1917_length_1201_cov_12.5_1 # 1 # 75 # 1 # ID=541_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.173,NODE_1917_length_1201_cov_12.5_1,1,75,+,Strict,940,21.557,mdsC,100,3000791,protein homolog model,n/a,n/a,monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GGAATAAAAGAAAAAAATGAAAAAGAGTTATTAAATATTAATCATTATGATGATTATTTAACTCTTTTAGATTGA,GIKEKNEKELLNINHYDDYLTLLD,MRTALIRMISKHNDGNGIMKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG,4.77,gnl|BL_ORD_ID|1088|hsp_num:0,1180,TRUE,loose hit with at least 95 percent identity pushed strict,ERS11702764.bin.r.1,ERS11702764-megahit_001
NODE_1170_length_2389_cov_19.1_1 # 2 # 118 # 1 # ID=273_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.342,NODE_1170_length_2389_cov_19.1_1,2,118,+,Strict,690,21.1718,MexJ,100,3003692,protein homolog model,n/a,n/a,macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,TCGCCTAATCTATGGTTGTTAAGTTTATTCTTAGCTGCTTGCGGATTGTTATTAAAAGTAGCTTCAAAAGTTGGTTTAATTGGACTACTTATGAGGGAAGATATTGATAAGGAGTAG,SPNLWLLSLFLAACGLLLKVASKVGLIGLLMREDIDKE,MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE,10.35,gnl|BL_ORD_ID|2015|hsp_num:0,2205,TRUE,loose hit with at least 95 percent identity pushed strict,ERS11702765.bin.r.3,ERS11702765-megahit_003
NODE_8088_length_1087_cov_9.5_2 # 537 # 1007 # -1 # ID=449_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_8088_length_1087_cov_9.5_2,537,1007,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS11702775.bin.r.7,ERS11702775-megahit_007
NODE_760_length_5662_cov_18.9_5 # 3151 # 3621 # 1 # ID=114_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_760_length_5662_cov_18.9_5,3151,3621,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS11702776.bin.r.3,ERS11702776-megahit_003
NODE_418_length_7589_cov_39.3_4 # 2030 # 2500 # -1 # ID=94_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_418_length_7589_cov_39.3_4,2030,2500,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS11702780.bin.r.7,ERS11702780-megahit_007
NODE_127_length_9358_cov_27.6_5 # 2687 # 3157 # 1 # ID=44_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_127_length_9358_cov_27.6_5,2687,3157,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS2985746.bin.r.2,ERS2985746-megahit_002
NODE_69_length_34304_cov_69.9_22 # 17629 # 18099 # 1 # ID=17_22;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_69_length_34304_cov_69.9_22,17629,18099,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS2985760.bin.r.1,ERS2985760-megahit_001
NODE_4419_length_3385_cov_158.5_4 # 2181 # 2651 # -1 # ID=191_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_4419_length_3385_cov_158.5_4,2181,2651,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS3636092.bin.r.3,ERS3636092-megahit_003
NODE_475_length_7162_cov_75.5_5 # 2038 # 2508 # -1 # ID=23_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_475_length_7162_cov_75.5_5,2038,2508,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS3774458.bin.r.1,ERS3774458-megahit_001
NODE_293_length_5367_cov_89.9_5 # 2865 # 3335 # 1 # ID=67_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_293_length_5367_cov_89.9_5,2865,3335,+,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS3774463.bin.r.1,ERS3774463-megahit_001
NODE_2397_length_4904_cov_30.2_3 # 1305 # 1775 # -1 # ID=114_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_2397_length_4904_cov_30.2_3,1305,1775,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS3774464.bin.r.12,ERS3774464-megahit_012
NODE_2243_length_5654_cov_60.3_4 # 2032 # 2502 # -1 # ID=131_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.323,NODE_2243_length_5654_cov_60.3_4,2032,2502,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS4042406.bin.r.13,ERS4042406-megahit_013
NODE_21_length_46614_cov_102.5_17 # 16761 # 17231 # -1 # ID=11_17;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_21_length_46614_cov_102.5_17,16761,17231,-,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGTGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205387.bin.r.6,ERS6205387-megahit_006
NODE_27_length_31216_cov_104.6_39 # 29516 # 29986 # 1 # ID=11_39;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_27_length_31216_cov_104.6_39,29516,29986,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGCGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205392.bin.r.3,ERS6205392-megahit_003
NODE_25_length_36060_cov_85.0_39 # 29455 # 29925 # 1 # ID=14_39;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_25_length_36060_cov_85.0_39,29455,29925,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205394.bin.r.3,ERS6205394-megahit_003
NODE_62_length_36324_cov_73.9_6 # 6362 # 6832 # -1 # ID=17_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_62_length_36324_cov_73.9_6,6362,6832,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205395.bin.r.5,ERS6205395-megahit_005
NODE_56_length_25362_cov_60.5_19 # 19655 # 20125 # -1 # ID=26_19;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_56_length_25362_cov_60.5_19,19655,20125,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205396.bin.r.4,ERS6205396-megahit_004
NODE_83_length_24024_cov_93.9_22 # 17430 # 17900 # 1 # ID=28_22;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_83_length_24024_cov_93.9_22,17430,17900,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205397.bin.r.3,ERS6205397-megahit_003
NODE_4899_length_1574_cov_10.7_2 # 216 # 686 # -1 # ID=367_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_4899_length_1574_cov_10.7_2,216,686,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205398.bin.r.9,ERS6205398-megahit_009
NODE_137_length_24214_cov_91.4_21 # 17607 # 18077 # 1 # ID=32_21;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_137_length_24214_cov_91.4_21,17607,18077,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205399.bin.r.4,ERS6205399-megahit_004
NODE_37_length_21720_cov_51.0_14 # 15988 # 16779 # -1 # ID=6_14;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.289,NODE_37_length_21720_cov_51.0_14,15988,16779,-,Strict,150,154.066,nimI,46.79,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGCCATGGTTTTTCTATGTTATTTATCTAGTAATTTATGAATTGCCACCATATTTCACTGCCAATCCAATTTATGTGGTATTCCTATTTGCTTTTTTGATTATGTTTGTTGGAATTATAAGGTCATTTTGGGTTGCGATTAAACTTTGGAATGTATATAATAATAATGAAAAATATGCATTAAATCCAACTGAGTTAAAAAATCCAAATAAAACTAAAGGAAACAATAATTATTCTATTATATTTTCATGTTGCTTATGTGTTATTATAATATTTTTAATATTTGCAATCAGTGCTATTTTATGAATTTTAGAGGATGTCATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MPWFFYVIYLVIYELPPYFTANPIYVVFLFAFLIMFVGIIRSFWVAIKLWNVYNNNEKYALNPTELKNPNKTKGNNNYSIIFSCCLCVIIIFLIFAISAILWILEDVMFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,152.91,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205401.bin.r.3,ERS6205401-megahit_003
NODE_1302_length_1346_cov_25.3_3 # 633 # 1103 # 1 # ID=409_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_1302_length_1346_cov_25.3_3,633,1103,+,Strict,150,151.754,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6205402.bin.r.2,ERS6205402-megahit_002
NODE_2729_length_3399_cov_13.3_3 # 754 # 1224 # 1 # ID=206_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_2729_length_3399_cov_13.3_3,754,1224,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6256688.bin.r.8,ERS6256688-megahit_008
NODE_259_length_17379_cov_93.4_17 # 17315 # 17377 # 1 # ID=36_17;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.270,NODE_259_length_17379_cov_93.4_17,17315,17377,+,Strict,1900,20.0162,MexW,100,3003031,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGAAATACCAGAAAATATACAACATCAATTAAACCAATTTCAACAATTACAACAACAAGCT,MEIPENIQHQLNQFQQLQQQA,MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH,2.06,gnl|BL_ORD_ID|2018|hsp_num:0,2208,TRUE,loose hit with at least 95 percent identity pushed strict,ERS6256693.bin.r.8,ERS6256693-megahit_008
NODE_2067_length_3545_cov_14.5_5 # 3410 # 3544 # 1 # ID=141_5;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.289,NODE_2067_length_3545_cov_14.5_5,3410,3544,+,Strict,2030,21.1718,ceoB,100,3003010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTTAATAGAAAAGGGTTTAGGTTTTATTATGGCTAGTTATATTAATCATCCATTATTGAGAAAAGATGCTATTGAATCACGTCTGTATCAACAAATTTTGGCAGGGGATGTATTAAAAAAAGGAAATACTATG,MLIEKGLGFIMASYINHPLLRKDAIESRLYQQILAGDVLKKGNTM,MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI,4.38,gnl|BL_ORD_ID|1148|hsp_num:0,1252,TRUE,loose hit with at least 95 percent identity pushed strict,ERS6256701.bin.r.8,ERS6256701-megahit_008
NODE_88_length_24321_cov_30.6_7 # 4078 # 4548 # 1 # ID=9_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_88_length_24321_cov_30.6_7,4078,4548,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGCGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6256704.bin.r.17,ERS6256704-megahit_017
NODE_1835_length_3945_cov_10.1_4 # 2062 # 2532 # -1 # ID=160_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_1835_length_3945_cov_10.1_4,2062,2532,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6256713.bin.r.10,ERS6256713-megahit_010
NODE_17_length_38243_cov_48.6_8 # 10231 # 10701 # -1 # ID=5_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_17_length_38243_cov_48.6_8,10231,10701,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6256726.bin.r.4,ERS6256726-megahit_004
NODE_117_length_22296_cov_28.2_17 # 17175 # 17645 # -1 # ID=22_17;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_117_length_22296_cov_28.2_17,17175,17645,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6256727.bin.r.3,ERS6256727-megahit_003
NODE_3053_length_2898_cov_52.2_2 # 533 # 1003 # 1 # ID=243_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_3053_length_2898_cov_52.2_2,533,1003,+,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6636085.bin.r.10,ERS6636085-megahit_010
NODE_5051_length_2501_cov_18.5_4 # 1894 # 2364 # -1 # ID=235_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_5051_length_2501_cov_18.5_4,1894,2364,-,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6636099.bin.r.15,ERS6636099-megahit_015
NODE_2659_length_3678_cov_28.5_6 # 2705 # 3175 # 1 # ID=117_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_2659_length_3678_cov_28.5_6,2705,3175,+,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERS6636154.bin.r.1,ERS6636154-megahit_001
NODE_399_length_29905_cov_23.9_4 # 1960 # 2430 # -1 # ID=14_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_399_length_29905_cov_23.9_4,1960,2430,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERSX0002001.bin.r.41,ERSX0002001-megahit_041
NODE_1918_length_7007_cov_41.6_8 # 4653 # 5123 # 1 # ID=65_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_1918_length_7007_cov_41.6_8,4653,5123,+,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERSX0003001.bin.r.22,ERSX0003001-megahit_022
NODE_24_length_74158_cov_496.6_20 # 19695 # 20165 # -1 # ID=2_20;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_24_length_74158_cov_496.6_20,19695,20165,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERSX0003002.bin.r.6,ERSX0003002-megahit_006
NODE_223_length_47693_cov_1521.3_39 # 27527 # 27997 # 1 # ID=9_39;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_223_length_47693_cov_1521.3_39,27527,27997,+,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERSX0003003.bin.r.35,ERSX0003003-megahit_035
NODE_805_length_3293_cov_8.5_1 # 67 # 537 # -1 # ID=48_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_805_length_3293_cov_8.5_1,67,537,-,Strict,150,150.599,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERSX0004057.bin.r.1,ERSX0004057-megahit_001
NODE_158_length_6581_cov_89.2_3 # 1329 # 1799 # -1 # ID=112_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_158_length_6581_cov_89.2_3,1329,1799,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",ERSX0004078.bin.r.4,ERSX0004078-megahit_004
NODE_2516_length_1011_cov_19.7_1 # 68 # 538 # -1 # ID=584_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_2516_length_1011_cov_19.7_1,68,538,-,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGTGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS11653538.bin.r.5,SRS11653538-megahit_005
NODE_3416_length_1016_cov_16.6_2 # 462 # 932 # 1 # ID=590_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_3416_length_1016_cov_16.6_2,462,932,+,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS11653539.bin.r.1,SRS11653539-megahit_001
NODE_1093_length_2458_cov_47.3_1 # 2 # 109 # -1 # ID=159_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.250,NODE_1093_length_2458_cov_47.3_1,2,109,-,Strict,1200,20.0162,tet(T),100,3000193,protein homolog model,n/a,n/a,tetracycline antibiotic,antibiotic target protection,tetracycline-resistant ribosomal protection protein,ATGGATGTTTTAATTATTGATTTAACTCATGGCGGAGTAAAAATAGCTATTAGCCTAGCTAAAAAAGGAAACTTTAATAAAATATATGGATATGATATTTACAATACT,MDVLIIDLTHGGVKIAISLAKKGNFNKIYGYDIYNT,MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN,5.53,gnl|BL_ORD_ID|1954|hsp_num:0,2037,TRUE,loose hit with at least 95 percent identity pushed strict,SRS11653591.bin.r.2,SRS11653591-megahit_002
NODE_835_length_8926_cov_20.0_5 # 2511 # 2981 # 1 # ID=25_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_835_length_8926_cov_20.0_5,2511,2981,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS15300787.bin.r.5,SRS15300787-megahit_005
NODE_132_length_36060_cov_186.4_39 # 29622 # 30092 # 1 # ID=22_39;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_132_length_36060_cov_186.4_39,29622,30092,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS15300792.bin.r.2,SRS15300792-megahit_002
NODE_1046_length_5598_cov_211.6_11 # 5392 # 5526 # -1 # ID=65_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.230,NODE_1046_length_5598_cov_211.6_11,5392,5526,-,Strict,2200,21.9422,Bifidobacterium bifidum ileS conferring resistance to mupirocin,100,3003730,protein homolog model,n/a,n/a,mupirocin-like antibiotic,antibiotic target alteration,antibiotic-resistant isoleucyl-tRNA synthetase (ileS),ATGAGTAGGAAAACAATTAATGTCAACAAAAAAATATACAATAAACTAAAAAGATGTAAAATAAAAGACACAGAAAGATATGCACAAGTAATCACAAGATTACTAAGTAAATATGAAAAGGAGTTGTTAAAATAA,MSRKTINVNKKIYNKLKRCKIKDTERYAQVITRLLSKYEKELLK,MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA,3.97,gnl|BL_ORD_ID|4694|hsp_num:0,2278,TRUE,loose hit with at least 95 percent identity pushed strict,SRS15300792.bin.r.2,SRS15300792-megahit_002
NODE_342_length_24111_cov_364.8_23 # 17633 # 18103 # 1 # ID=28_23;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_342_length_24111_cov_364.8_23,17633,18103,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS15300800.bin.r.2,SRS15300800-megahit_002
NODE_770_length_8328_cov_41.3_11 # 8115 # 8306 # 1 # ID=71_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.365,NODE_770_length_8328_cov_41.3_11,8115,8306,+,Strict,1020,22.3274,tlrC,100,3002827,protein homolog model,n/a,n/a,macrolide antibiotic; lincosamide antibiotic,antibiotic target protection,Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins,ATGATTAAGGTTCAAAATATTTGCAAAACATACAAGGTCGCAAAAAGAAATAAGGGCTTAAAAGAAGCAGCAAAGGCTCTTTTTAAGAGGGACTATGAATATGTAAAAGCCTTAAACGATATTTCTTTTTCGATTAACGAAGGAGAAACCGTAGGTTACATCGGGCCGAACGGAGCCGGAAAGAGTTTTTAA,MIKVQNICKTYKVAKRNKGLKEAAKALFKRDYEYVKALNDISFSINEGETVGYIGPNGAGKSF,MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR,11.5,gnl|BL_ORD_ID|1841|hsp_num:1,1997,TRUE,loose hit with at least 95 percent identity pushed strict,SRS15300802.bin.r.16,SRS15300802-megahit_016
NODE_1023_length_6990_cov_37.9_2 # 511 # 981 # 1 # ID=100_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_1023_length_6990_cov_37.9_2,511,981,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS15300802.bin.r.16,SRS15300802-megahit_016
NODE_5354_length_1755_cov_14.5_3 # 1410 # 1754 # -1 # ID=356_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.272,NODE_5354_length_1755_cov_14.5_3,1410,1754,-,Strict,50,64.3142,vanW gene in vanI cluster,39.44,3003724,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,TATAAACCTGCAGGAACTTTTCTAAATCATAAGATAGTGGATTCAATTGGTGGAGGAATCTGTCAAGTCACATCTACCTTATATCAAGCATTAGTAAAATCTGATTTAAAAATAATTGAAAGAAATCAACATTCTATGAGAGTACCTTATTGTACTATTGGATTAGATGCGATGTATTATGAAGGACAAAGTAATTTAAAATTTAAAAATTCATTTTGTGAACATGCATCTTTAAAAGTGTTAATTAATTCTTTTGAAAGATCCTCACCACCTACAATGCAAATTTCAGTCTCAACATTTATTTCAGTTAAACAATCATATAATGCATCTAAATTTTTACCATAA,YKPAGTFLNHKIVDSIGGGICQVTSTLYQALVKSDLKIIERNQHSMRVPYCTIGLDAMYYEGQSNLKFKNSFCEHASLKVLINSFERSSPPTMQISVSTFISVKQSYNASKFLP,MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK,30.56,gnl|BL_ORD_ID|4746|hsp_num:0,2242,,"",SRS3078158.bin.r.1,SRS3078158-megahit_001
NODE_2094_length_10094_cov_38.6_8 # 5035 # 5505 # 1 # ID=62_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_2094_length_10094_cov_38.6_8,5035,5505,+,Strict,150,151.754,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS3078204.bin.r.13,SRS3078204-megahit_013
NODE_637_length_13794_cov_35.5_16 # 11450 # 11920 # 1 # ID=42_16;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_637_length_13794_cov_35.5_16,11450,11920,+,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS4625245.bin.r.11,SRS4625245-megahit_011
NODE_2187_length_2749_cov_26.0_3 # 1034 # 1504 # -1 # ID=251_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_2187_length_2749_cov_26.0_3,1034,1504,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS4625248.bin.r.7,SRS4625248-megahit_007
NODE_637_length_23359_cov_389.2_28 # 20814 # 21284 # 1 # ID=36_28;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_637_length_23359_cov_389.2_28,20814,21284,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS473746.bin.r.50,SRS473746-megahit_050
NODE_16_length_79082_cov_308.6_27 # 30535 # 31005 # -1 # ID=5_27;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.323,NODE_16_length_79082_cov_308.6_27,30535,31005,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGCGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS6212649.bin.r.2,SRS6212649-megahit_002
NODE_510_length_7149_cov_90.8_4 # 2011 # 2481 # -1 # ID=95_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_510_length_7149_cov_90.8_4,2011,2481,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS6212655.bin.r.1,SRS6212655-megahit_001
NODE_454_length_5570_cov_37.2_5 # 3208 # 3678 # 1 # ID=112_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.316,NODE_454_length_5570_cov_37.2_5,3208,3678,+,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS6212656.bin.r.2,SRS6212656-megahit_002
NODE_401_length_7157_cov_186.2_4 # 2033 # 2503 # -1 # ID=87_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_401_length_7157_cov_186.2_4,2033,2503,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS6212663.bin.r.5,SRS6212663-megahit_005
NODE_13_length_44297_cov_212.2_40 # 27547 # 28017 # 1 # ID=13_40;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.314,NODE_13_length_44297_cov_212.2_40,27547,28017,+,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGTGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS7212788.bin.r.2,SRS7212788-megahit_002
NODE_1823_length_3047_cov_26.6_4 # 1657 # 2127 # -1 # ID=234_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_1823_length_3047_cov_26.6_4,1657,2127,-,Strict,150,152.91,nimI,47.02,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGACTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLTLLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS7212789.bin.r.6,SRS7212789-megahit_006
NODE_5580_length_1101_cov_14.6_1 # 1 # 69 # 1 # ID=457_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.232,NODE_5580_length_1101_cov_14.6_1,1,69,+,Strict,600,19.631,SGM-7,100,3006993,protein homolog model,n/a,n/a,carbapenem,antibiotic inactivation,SGM beta-lactamase,GAATCAATTGTAGCTTATCACAAATATGAAGAAGAATTATTTAAAAATAAAAAAAGAGGAAGGTATTAG,ESIVAYHKYEEELFKNKKRGRY,MALRKSLSLAALTACLVVALPLSAAPKKKAPAKKVEEVPTLPTLLPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCSTFKAPLAAAVLIGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAAAAVEVSDNSAANLLLPMLGGPEGLTSFIRAHGDKITRLDRIEPDLNENIAGDPRDTTSPAAMAGLMGRLLFRDMAAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDKKAEAAIAEAAHSALEFVSKAQKSGLN,6.75,gnl|BL_ORD_ID|4580|hsp_num:0,5650,TRUE,loose hit with at least 95 percent identity pushed strict,SRS7212789.bin.r.6,SRS7212789-megahit_006
NODE_380_length_1843_cov_22.5_1 # 3 # 245 # 1 # ID=303_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.247,NODE_380_length_1843_cov_22.5_1,3,245,+,Strict,500,22.3274,MYX-1,100,3006955,protein homolog model,n/a,n/a,carbapenem,antibiotic inactivation,MYX beta-lactamase,GATGATGAAGCTATTGATGAGTTAGTTAAACTTAATGAAAAATATAAGATTAATATAGCTTTTGAAGGTGGAGAAGCAGAAAGTTTAGCTATTGATGGACCTATATTTAAAAAAAGAATTAAAATTTTAAAAGATAGAAAAGAATGGCACAGGGATAGTGGTGTGTATATTATTGAAGATGCTATCTTAGAAGATAAATGATTTATAAATCAATTTCTTCTAAAAATTTACTTATTTTATTAG,DDEAIDELVKLNEKYKINIAFEGGEAESLAIDGPIFKKRIKILKDRKEWHRDSGVYIIEDAILEDKWFINQFLLKIYLFY,MTLFPLRWFCAGALLITLSTACTRSTPAATVERNIPVKAQSQGPDEYVLADDVSVRKLAPGVWLHITVVTLEPFGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAAVVTHFHEDRLGGVPALAPHGIPVHGLEETARIATSLGLPGPTETFAKTSTVDSLELFFPGAGHAKDNIVVWHRDSGVLFGGCFVKDGASTNLGNVADADVAAWPASLSRTRQRFPEARVVVPGHGQPGGPELLGHTEALLR,30.65,gnl|BL_ORD_ID|3707|hsp_num:0,4777,TRUE,loose hit with at least 95 percent identity pushed strict,SRS7212790.bin.r.1,SRS7212790-megahit_001
NODE_147_length_8674_cov_61.2_5 # 3672 # 4361 # -1 # ID=90_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.291,NODE_147_length_8674_cov_61.2_5,3672,4361,-,Strict,150,155.221,nimI,46.15,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTGTTGGAATTATAAGGTCATTTTGGGTTGCGATTAAACTTTGGAATGTATATGATAATAATGAAAAATATGCATTAAATCCAACTGAGTTAAAAAATCCAAATAAAACTAAAGGAAACAATAATTATTCTACTATATTTTCATGTTGCTTATGTGTTATTATAATATTTTTAATATTTGCAATCAGTGCTATTTTATGAATTTTAGAGGATGTCATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCAGTAAAATAGTTGAAGAAAATTAA,MFVGIIRSFWVAIKLWNVYDNNEKYALNPTELKNPNKTKGNNNYSTIFSCCLCVIIIFLIFAISAILWILEDVMFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSSKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,133.14,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS7212800.bin.r.1,SRS7212800-megahit_001
NODE_120_length_7446_cov_25.4_3 # 1598 # 2068 # 1 # ID=21_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_120_length_7446_cov_25.4_3,1598,2068,+,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS7212801.bin.r.7,SRS7212801-megahit_007
NODE_673_length_4117_cov_19.4_1 # 42 # 512 # -1 # ID=33_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_673_length_4117_cov_19.4_1,42,512,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS7212802.bin.r.1,SRS7212802-megahit_001
NODE_2869_length_1757_cov_18.5_1 # 3 # 167 # -1 # ID=337_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.309,NODE_2869_length_1757_cov_18.5_1,3,167,-,Strict,2030,21.1718,ceoB,100,3003010,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTTAATAGAAAAGGGTTTAGGTTTTATTATGGCTAGTTATATTAATCATCCATTATTGAGAAAAGATGCTATTGAATCACGTCTGTATCAACAAATTTTGGCAGGGGATGTATTAAAAAAAGGAAATACTATGGTTGTTGCACCTACAGCATTAGGTAAAACA,MLIEKGLGFIMASYINHPLLRKDAIESRLYQQILAGDVLKKGNTMVVAPTALGKT,MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI,5.36,gnl|BL_ORD_ID|1148|hsp_num:0,1252,TRUE,loose hit with at least 95 percent identity pushed strict,SRS7212802.bin.r.1,SRS7212802-megahit_001
NODE_27_length_25433_cov_49.3_19 # 19679 # 20149 # -1 # ID=16_19;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.321,NODE_27_length_25433_cov_49.3_19,19679,20149,-,Strict,150,154.066,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTCGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAAGGCATTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAGTCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGAAGAAACTGCTGATGAAATCAGAAGACTATTGGATAAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGCGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPRGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIRHCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRVRILKDNDEKIEKLTCLGDKFNKAHEETADEIRRLLDKTEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS7212804.bin.r.3,SRS7212804-megahit_003
NODE_543_length_2660_cov_12.2_3 # 829 # 1299 # -1 # ID=64_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.318,NODE_543_length_2660_cov_12.2_3,829,1299,-,Strict,150,151.754,nimI,47.68,3007111,protein homolog model,n/a,n/a,nitroimidazole antibiotic,antibiotic inactivation,nitroimidazole reductase,ATGTTTAGAAAAATGAGAAGAAAAGGTCAAGAGATCACAGAAAGTGAATGCATTGAAATATTAACTAATCAACCTAGTGGAGTATTGGCTCTTTTAGGTGATTATGATTATCCTTATGCAGTTCCTATGAGTCATGTATATGTTGATGGTAAAATATACTTCCATGGGGCTATGGAAGGACATAAAAATGATGCTATAATGCGTTGTGATAAAGTTTCCTATTGTGTTGTGAACAATGGAGTTTTAAATGATGATTGCTGGTCTTATACATTTAAAAGCGTTATTGTCTTTGGAAGAATCAGAATATTGAAGGATAATGATGAAAAAATTGAAAAATTAACCTGTCTTGGAGATAAATTCAACAAGGCACATGGAGAAACTGCTGATGAAATCAGAAGACTATTGGATGAAACTGAAGTCTTTGAAATTACTATTGAGCATATGAGTGGTAAAATAGTTGAAGAAAATTAA,MFRKMRRKGQEITESECIEILTNQPSGVLALLGDYDYPYAVPMSHVYVDGKIYFHGAMEGHKNDAIMRCDKVSYCVVNNGVLNDDCWSYTFKSVIVFGRIRILKDNDEKIEKLTCLGDKFNKAHGETADEIRRLLDETEVFEITIEHMSGKIVEEN,MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA,90.7,gnl|BL_ORD_ID|4788|hsp_num:0,5784,,"",SRS7967575.bin.r.2,SRS7967575-megahit_002
